Just caught that Oppenheimer upgraded Oracle back in February - moved it from Perform to Outperform. Pretty interesting timing given everything else going on. They're looking at like $286 price target, which would be almost 96% upside from where it was trading. The forecasts are all over the place though, ranging from $156 to $420, so take that with a grain of salt.

What caught my eye was the fund positioning. So Oppenheimer's bullish, but institutions have been pretty mixed on this. Vanguard's actually been loading up - increased their ORCL position by over 40% last quarter. JPMorgan though? They cut their stake by 20%, so not everyone's convinced. The put/call ratio is sitting at 0.88 which leans bullish, but the total institutional ownership actually dipped about 3% in the last few months.

Revenue projections are looking at a slight decline of 2.76%, and EPS down 1.36% from prior estimates. So the Oppenheimer call seems to be betting on something beyond just near-term numbers. Could be interesting to watch how this plays out over the next quarter.